Validation of a deep learning–based AI system for HER2-targeted breast cancer assessment using ultrasound imaging in a clinical setting

Validation of a deep learning–based AI system for HER2-targeted breast cancer assessment using ultrasound imaging in a clinical setting

BackgroundThis study evaluates the performance of a deep learning–based artificial intelligence (AI) system developed under the Stradexa (a branded form of doxorubicin used regionally in South Africa) initiative, designed for real-time risk stratification and treatment monitoring in HER2-positive br...

Full description

Saved in:
Bibliographic Details
Main Author: Kathryn Malherbe
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
artificial intelligence - AI
deep machine learning algorithms
risk prediction algorithm
ultrasound
chemotherapy - oncology
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1639474/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items